Publicaciones en colaboración con investigadores/as de Hospital Ramón y Cajal (2)

2021

  1. Osimertinib in advanced EGFR-T790M mutation-positive non-small cell lung cancer patients treated within the Special Use Medication Program in Spain: OSIREX-Spanish Lung Cancer Group

    BMC Cancer, Vol. 21, Núm. 1

2018

  1. Impact of a barcode medication administration system on patient safety

    Oncology Nursing Forum, Vol. 45, Núm. 1, pp. E1-E13